Dimension Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The following report cites that the company conducts pre-clinical trials of their drugs on animals.
“Beyond our current pipeline of programs, we plan to disclose three new rare disease programs in 2016. We select our programs based on demonstrated preclinical proof of concept in well-described or validated animal models.” (Page 15) Read the full document.
Dimension Therapeutics, Inc. engages in the provision of medical development. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz on October 2013, and is headquartered in Cambridge, MA. [Source: MarketWatch]
Company Website: http://dimensiontx.com